摘要
脊椎动物视网膜的结构和发育机制是高度保守的。在retinogenesis最有特色的活动之一是在时间和空间上的多能视网膜祖细胞七种类型的视网膜细胞的产生。通过基因表达和蛋白质功能的多样性调制的重要性以及在这一过程中调控SUMO化患病率已越来越欣赏。在这里,我们回顾在视网膜发育的SUMO化修饰的生物学意义,探讨SUMO化平衡和视网膜祖细胞退出细胞周期增殖的分子机制,并探讨通过多种转录因子调制调解不同视网膜神经元和光感受器的规范。在正常视网膜功能的SUMO化修饰的潜在作用是由SUMO化机械关键部件在小鼠视网膜的表达,也是以高度保守的SUMO化修饰位点对神经节细胞的神经递质受体为例。
关键词: 视网膜发育,SUMO化修饰,SUMO1 / 2 / 3,感光器规格,转录因子,神经递质。
Current Molecular Medicine
Title:SUMOylation Regulation of Retina Development and Functions
Volume: 16 Issue: 9
Author(s): L. Zhang, D. W.-C. Li
Affiliation:
关键词: 视网膜发育,SUMO化修饰,SUMO1 / 2 / 3,感光器规格,转录因子,神经递质。
摘要: The structure and developmental mechanisms of vertebrate retina are highly conserved. One of the most distinctive events during retinogenesis is the temporally and spatially generation of seven types of retinal cells from the multipotent retinal progenitor cells. The importance and prevalence of SUMOylation in regulation of this process through modulation of gene expression and protein function diversity have been increasingly appreciated. Here, we review the biological significance of SUMOylation in retina development, examine how SUMOylation balances the proliferation and cell cycle exit of retinal progenitor cells, and finally discuss the molecular mechanisms mediating the specification of different retina neurons and photoreceptors through modulation of various transcription factors. The potential role of SUMOylation in normal retina function is illustrated by the abundant expression of key components of SUMOylation machinery in mouse retina, and is also exemplified by the highly conserved SUMOylation site on neurotransmission receptors in ganglion cells.
Export Options
About this article
Cite this article as:
L. Zhang, D. W.-C. Li , SUMOylation Regulation of Retina Development and Functions, Current Molecular Medicine 2016; 16 (9) . https://dx.doi.org/10.2174/1566524016666161128115453
DOI https://dx.doi.org/10.2174/1566524016666161128115453 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis
CNS & Neurological Disorders - Drug Targets Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Current Pharmaceutical Design Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators
Current Topics in Medicinal Chemistry MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy
Current Cancer Drug Targets The Effect of Lipoic Acid on Macro and Trace Metal Levels in Living Tissues Exposed to Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
Current Pharmaceutical Biotechnology Protein Phosphatase Inhibition: Structure Based Design. Towards New Therapeutic Agents
Current Pharmaceutical Design α(N)-Heterocyclic Thiosemicarbazones: Iron Chelators that are Promising for Revival of Gallium in Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy
Current Drug Targets Curcumin: the Yellow Molecule with Pleiotropic Biological Effects
Letters in Drug Design & Discovery The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery The Tribbles-1 Protein in Humans: Roles and Functions in Health and Disease
Current Molecular Medicine Safety Concerns Related to Hematopoietic Stem Cell Gene Transfer Using Retroviral Vectors
Current Gene Therapy Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Current Cancer Drug Targets OX40:OX40L Axis: Emerging Targets for Immunotherapy of Human Disease
Current Immunology Reviews (Discontinued) Ribonucleotide Reductase as One Important Target of [Tris(1,10- phenanthroline)lanthanum(III)] Trithiocyanate (KP772)
Current Cancer Drug Targets Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Current Gene Therapy Targeting Cancer Stem Cells with Natural Products
Current Drug Targets Coumarins as Antioxidants
Current Medicinal Chemistry Role of Growth Factors in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis
Current Rheumatology Reviews